PA8810701A1 - Derivados de 19-nor-esteroide que tiene un grupo 15a,16a-metileno y un anillo de 17,17-espirolactona saturado, su uso y medicamentos que los comprenden - Google Patents

Derivados de 19-nor-esteroide que tiene un grupo 15a,16a-metileno y un anillo de 17,17-espirolactona saturado, su uso y medicamentos que los comprenden

Info

Publication number
PA8810701A1
PA8810701A1 PA20088810701A PA8810701A PA8810701A1 PA 8810701 A1 PA8810701 A1 PA 8810701A1 PA 20088810701 A PA20088810701 A PA 20088810701A PA 8810701 A PA8810701 A PA 8810701A PA 8810701 A1 PA8810701 A1 PA 8810701A1
Authority
PA
Panama
Prior art keywords
hydrogen
group
derivatives
understand
methylene
Prior art date
Application number
PA20088810701A
Other languages
English (en)
Inventor
Ulrich Klar
Joachim Kuhnke
Rolf Bohlmann
Jan Huebner
Sven Ring
Thomas Frenzel
Frederik Menges
Steffen Borden
Katja Prelle
Hans Peter Muhn
Original Assignee
Bayer Schering Pharma Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=40548690&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=PA8810701(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Bayer Schering Pharma Ag filed Critical Bayer Schering Pharma Ag
Publication of PA8810701A1 publication Critical patent/PA8810701A1/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J21/00—Normal steroids containing carbon, hydrogen, halogen or oxygen having an oxygen-containing hetero ring spiro-condensed with the cyclopenta(a)hydrophenanthrene skeleton
    • C07J21/001—Lactones
    • C07J21/003—Lactones at position 17
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/12—Drugs for genital or sexual disorders; Contraceptives for climacteric disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/18—Feminine contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
    • A61P5/26—Androgens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
    • A61P5/30—Oestrogens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
    • A61P5/34—Gestagens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/38—Drugs for disorders of the endocrine system of the suprarenal hormones
    • A61P5/42—Drugs for disorders of the endocrine system of the suprarenal hormones for decreasing, blocking or antagonising the activity of mineralocorticosteroids
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J53/00—Steroids in which the cyclopenta(a)hydrophenanthrene skeleton has been modified by condensation with a carbocyclic rings or by formation of an additional ring by means of a direct link between two ring carbon atoms, including carboxyclic rings fused to the cyclopenta(a)hydrophenanthrene skeleton are included in this class
    • C07J53/002—Carbocyclic rings fused
    • C07J53/004—3 membered carbocyclic rings
    • C07J53/008—3 membered carbocyclic rings in position 15/16

Landscapes

  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Endocrinology (AREA)
  • Diabetes (AREA)
  • Reproductive Health (AREA)
  • Gynecology & Obstetrics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Steroid Compounds (AREA)
  • Medicinal Preparation (AREA)

Abstract

LOS DERIVADOS DE y-LACTONA DEL ÁCIDO 15ALFA,16ALFA-METILEN-17-HIDROXI-19-NOR-17-PREGNA-4-en-3-ona-21-CARBOXÍLICO DE LA PRESENTE INVENCIÓN POSEEN EFECTIVIDAD GESTAGÉNICA.TIENEN LA FÓRMULA QUÍMICA GENERAL I,EN LA CUAL Z SE SELECCIONA DEL GRUPO QUE COMPRENDE UN ÁTOMO DE OXÍGENO,DOS ÁTOMOS DE HIDRÓGENO,NOR Y NNHSO2R,DONDE R ES HIDRÓGENO,ALQUILO-C1-C10,ARILO O ARALQUILO-C7-C20,R4 ES HIDRÓGENO O HALÓGENO;ADEMÁS,R6A,R6B FORMAN JUNTOS METILENO O 1,2-ETANDIILO O R6A ES HIDRÓGENO Y R6B SE SELECCIONA DEL GRUPO QUE COMPRENDE HIDRÓGENO,ALQUILO-C1-C10,ALQUENILO-C2-C10 oALQUINILO-C2-C10,Y R7 SE SELECCIONA DEL GRUPO QUE COMPRENDE HIDRÓGENO,ALQUILO-C1-C10,CICLOALQUILO-C3-C6,ALQUENILO-C2-C10 o ALQUINILO-C2-C10,o:R6A ES HIDRÓGENO Y R6B Y R7JUNTOS FORMAN UN ENLACE,UN OXÍGENO O METILENO,R18 REPRESENTA HIDRÓGENO O ALQUILO-C1-C3 Y COMPRENDEN ADEMÁS SUS SOLVATOS,HIDRATOS,ESTEREOISÓMEROS Y SALES.
PA20088810701A 2007-12-29 2008-12-24 Derivados de 19-nor-esteroide que tiene un grupo 15a,16a-metileno y un anillo de 17,17-espirolactona saturado, su uso y medicamentos que los comprenden PA8810701A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE102007063495A DE102007063495A1 (de) 2007-12-29 2007-12-29 19-Nor-Steroidderivate mit einer 15α,16α-Methylengruppe und einem gesättigten 17,17-Spirolactonring, deren Verwendung sowie diese Derivate enthaltende Arzneimittel

Publications (1)

Publication Number Publication Date
PA8810701A1 true PA8810701A1 (es) 2009-12-16

Family

ID=40548690

Family Applications (1)

Application Number Title Priority Date Filing Date
PA20088810701A PA8810701A1 (es) 2007-12-29 2008-12-24 Derivados de 19-nor-esteroide que tiene un grupo 15a,16a-metileno y un anillo de 17,17-espirolactona saturado, su uso y medicamentos que los comprenden

Country Status (26)

Country Link
US (2) US20100311702A1 (es)
EP (1) EP2238149B1 (es)
JP (1) JP5600071B2 (es)
KR (1) KR20100102136A (es)
CN (1) CN101910192B (es)
AR (1) AR069962A1 (es)
AU (1) AU2008342916A1 (es)
BR (1) BRPI0821666A2 (es)
CA (1) CA2710495C (es)
CL (1) CL2008003919A1 (es)
CO (1) CO6290675A2 (es)
DE (1) DE102007063495A1 (es)
DO (1) DOP2010000199A (es)
EA (1) EA201000982A1 (es)
EC (1) ECSP10010315A (es)
ES (1) ES2539121T3 (es)
HK (1) HK1151532A1 (es)
IL (1) IL206019A0 (es)
NZ (1) NZ586453A (es)
PA (1) PA8810701A1 (es)
PE (1) PE20091336A1 (es)
TW (1) TW200940074A (es)
UA (1) UA98834C2 (es)
UY (1) UY31580A1 (es)
WO (1) WO2009083272A2 (es)
ZA (1) ZA201005395B (es)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8334375B2 (en) * 2009-04-10 2012-12-18 Evestra, Inc. Methods for the preparation of drospirenone
WO2012059594A1 (en) 2010-11-04 2012-05-10 Bayer Pharma Aktiengesellschaft Mineralcorticoid receptor antagonists for the treatment of corticoid-induced obesity
TW201350122A (zh) * 2012-04-23 2013-12-16 Bayer Pharma AG １８－甲基－１５β，１６β－亞甲基－１９－降－２０－螺氧－４－烯－３－酮的子宮內用途，包含１８－甲基－１５β，１６β－亞甲基－１９－降－２０－螺氧－４－烯－３－酮的子宮內系統，及其於避孕及婦科治療之用途

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE1183500B (de) 1962-10-12 1964-12-17 Schering Ag Verfahren zur Herstellung von alpha, beta-Methylenketonen der Steroidreihe
US3705179A (en) 1971-03-15 1972-12-05 American Home Prod Antiandrogenic steroids
US4188951A (en) * 1972-08-17 1980-02-19 Alza Corporation Intrauterine system embracing selected copolymeric membranes for administering beneficial agent
NL7701384A (nl) 1977-02-10 1978-08-14 Akzo Nv Werkwijze voor het bereiden van nieuwe steroiden van de oestraanreeks.
DE2922500A1 (de) 1979-05-31 1980-12-04 Schering Ag 6 beta .7 beta
DE3402329A1 (de) 1984-01-20 1985-08-01 Schering AG, 1000 Berlin und 4709 Bergkamen 6,6-ethylen-15,16-methylen-3-oxo-17(alpha)-pregn-4-en-21,17-carbolactone, verfahren zu deren herstellung und diese enthaltende pharmazeutische praeparate
DE19651000A1 (de) 1996-12-01 1998-06-04 Schering Ag Oxyiminopregnancarbolactone
US8445469B2 (en) * 2004-12-30 2013-05-21 Bayer Intellectual Property Gmbh 18-methyl-19-nor-17-pregn-4-ene-21,17-carbolactones, as well as pharmaceutical preparations that contain the latter
DE102004063864A1 (de) * 2004-12-30 2006-07-13 Schering Ag 18-Methyl-19-nor-17-pregn-4-en21,17-carbolactone, sowie diese enthaltende pharmazeutische Präparate
WO2009111574A2 (en) * 2008-03-05 2009-09-11 Evestra, Inc. BISMETHYLENE-17α CARBOLACTONES AND RELATED USES

Also Published As

Publication number Publication date
EA201000982A1 (ru) 2011-02-28
US20130123219A1 (en) 2013-05-16
DOP2010000199A (es) 2010-10-15
BRPI0821666A2 (pt) 2015-06-16
WO2009083272A3 (de) 2009-08-27
JP5600071B2 (ja) 2014-10-01
CL2008003919A1 (es) 2010-05-07
UA98834C2 (ru) 2012-06-25
US20100311702A1 (en) 2010-12-09
AR069962A1 (es) 2010-03-03
CA2710495C (en) 2015-04-28
AU2008342916A1 (en) 2009-07-09
EP2238149A2 (de) 2010-10-13
PE20091336A1 (es) 2009-10-04
CO6290675A2 (es) 2011-06-20
CA2710495A1 (en) 2009-07-09
CN101910192A (zh) 2010-12-08
EP2238149B1 (de) 2015-03-18
NZ586453A (en) 2012-05-25
ES2539121T3 (es) 2015-06-26
JP2011507928A (ja) 2011-03-10
KR20100102136A (ko) 2010-09-20
CN101910192B (zh) 2013-07-31
DE102007063495A1 (de) 2009-09-17
TW200940074A (en) 2009-10-01
HK1151532A1 (es) 2012-02-03
WO2009083272A2 (de) 2009-07-09
IL206019A0 (en) 2010-11-30
US8987239B2 (en) 2015-03-24
ZA201005395B (en) 2012-01-25
UY31580A1 (es) 2009-08-03
ECSP10010315A (es) 2010-08-31

Similar Documents

Publication Publication Date Title
PA8784201A1 (es) Derivado de 17b-ciano-18a-homo-19-nor-androst-4-eno, su uso y medicamento que lo contiene
GT201200346A (es) Derivados de imidazopiridina, su procedimiento de preparaciòn y su aplicaciòn en terapèutica
CL2017000804A1 (es) Derivados espirodiamina como inhibidores de la aldosterona sintasa
NI200900042A (es) Nuevo derivados de dismetina, su procedimiento de preparación y las composiciones farmacéuticas que los contienen.
CO7400872A2 (es) Derivados sustituidos de ftalazin-1(2h)-ona
CR11546A (es) Derivados de carboxamidas azabiciclicas, su preparacion y su aplicacion en terapeutica
UY30498A1 (es) Nueva clase de compuestos de benzimidazolilo, sus sales, composiciones farmacéuticas conteniéndolos y aplicaciones
CR11251A (es) Depsipeptidos ciclicos y usos de los mismos
BR112016001979A2 (pt) composto de tetrazolinona e uso do mesmo
CR8889A (es) Derivados de n-(1h-indolil)- 1h-indol-2- carboxamidas, su preparacion y su aplicacion en terapeutica
CR20140135A (es) Nuevos derivados de aril-quinolina
NI201000134A (es) Nuevos derivados dihidroindolonas, su procedimiento de preparacion y las composiciones farmaceuticas que los contienen.
PA8784401A1 (es) Derivado de 17b-ciano-19-nor-androst-4-eno, su uso y medicamento que lo contiene
PA8810701A1 (es) Derivados de 19-nor-esteroide que tiene un grupo 15a,16a-metileno y un anillo de 17,17-espirolactona saturado, su uso y medicamentos que los comprenden
AR088034A1 (es) Compuesto de amina ciclica util como pesticida
AR077429A1 (es) Compuestos hidroxiasenapina sus derivados y composiciones farmaceuticas que comprenden los mismos
CR11544A (es) Derivado 15,16-metilen-17-(1'-propenil)-17-3'-oxidoestra-4-3-ona, su uso y medicamento que lo contiene
CO2020010970A2 (es) Conjugados de fármacos de molécula pequeña de monofosfato de gemcitabina
CU20130037A7 (es) Nuevos derivados dihidrobenzoxatiazepinas, su procedimiento de preparación y las composiciones farmacéuticas que los contienen
CU20100137A7 (es) Derivados de 19-nor-esteroide que tiene un grupo 15, 16-metileno y un anillo de 17, 17-espirolactona saturado, su uso y medicamentos que los comprenden
PA8809901A1 (es) Derivado de y-lactona de esteroide de ácido 15, 16-metilen-17-hidroxi-19-nor-21-carboxílico, su uso y medicamento que lo contiene
PA8809701A1 (es) Derivado de y-lactona del esteroide del ´cido 17-hidroxi-19-nor-21-carboxílico, su uso y el medicamento que lo contiene
CR11541A (es) Derivado de 17-(1 -propenil)-17-3 -oxidoestra-4-en-3-ona, su uso y medicamentos que lo contienen
CR11567A (es) Nuevos compuestos piperidinicos, su procedimiento de preparacion y las composiciones farmaceuticas que los contienen
TH104955A (th) อนุพันธ์ 19-นอร์-สเตอรอยด์ กับหมู่ 15(อัลฟา),16(อัลฟา)-เมทธิลีน และ ริง 17,17-สไปโรแลคโตน ชนิดอิ่มตัว การใช้สารเหล่านี้และผลิตภัณฑ์ยาที่มีอนุพันธ์เหล่านี้